Literature DB >> 25049076

Homo- and hetero-oligomerization of β2-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology.

Artur Wnorowski1, Krzysztof Jozwiak2.   

Abstract

The β2-adrenergic receptor (β2AR) is the prototypic member of G protein-coupled receptors (GPCRs) involved in the production of physiological responses to adrenaline and noradrenaline. Research done in the past few years vastly demonstrated that β2AR can form homo- and hetero-oligomers. Despite the fact that currently this phenomenon is widely accepted, the spread and relevance of β2AR oligomerization are still a matter of debate. This review considers the progress achieved in the field of β2AR oligomerization with focus on the implications of the receptor-receptor interactions to β2AR trafficking, pharmacology and downstream signal transduction pathways.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta-adrenoceptor; Oligomerization interface; Receptor mosaic; Receptorosome; Receptor–receptor interaction

Mesh:

Substances:

Year:  2014        PMID: 25049076     DOI: 10.1016/j.cellsig.2014.06.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  4 in total

Review 1.  Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.

Authors:  Takanobu Takezako; Hamiyet Unal; Sadashiva S Karnik; Koichi Node
Journal:  Pharmacol Res       Date:  2017-06-23       Impact factor: 7.658

2.  CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons.

Authors:  Tayla A Rees; Andrew F Russo; Simon J O'Carroll; Debbie L Hay; Christopher S Walker
Journal:  Front Physiol       Date:  2022-05-10       Impact factor: 4.755

3.  Prognostic significance of β2-adrenergic receptor expression in malignant melanoma.

Authors:  Akira Shimizu; Kyoichi Kaira; Keita Mori; Madoka Kato; Kimihiro Shimizu; Masahito Yasuda; Ayumi Takahashi; Tetsunari Oyama; Takayuki Asao; Osamu Ishikawa
Journal:  Tumour Biol       Date:  2015-11-23

4.  To block it, or not to block it?

Authors:  Artur Wnorowski
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-27       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.